Sonic Healthcare Limited
Sonic Healthcare Limited
- P/E ratio
- 16.32
Your view on SHL.AX
Overview
What the company does, where it operates, and who runs it.
About Sonic Healthcare Limited
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- James Pacey Newcombe
- Headquarters
- Grosvenor Place, Sydney, NSW, AU
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- James Pacey Newcombe
- Headquarters
- Grosvenor Place, Sydney, NSW, AU
Sonic Healthcare Limited delivers medical diagnostic services to a diverse clientele, including medical professionals, hospitals, public health organizations, and individual patients.
The company's services encompass a broad spectrum of laboratory medicine and pathology testing, covering biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal diagnostics, toxicology, and other related functions.
Furthermore, Sonic provides extensive radiology services, such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry.
Its offerings also extend to primary care medical services, featuring general practice clinics, occupational health, specialized skin cancer clinics, after-hours GP services, IT solutions for general practices, and various community-based healthcare programs.
Operating internationally, the company has a significant presence in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, and Belgium. Founded in 1934, Sonic Healthcare Limited is headquartered in Sydney, Australia.
Stock Data
Price chart, volume, and trading data.
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Sonic Healthcare Limited from FRC's valuation model, read against the market price. SHL.AX last traded at AUD 22.25, 16.3× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Sonic Healthcare Limited. Starting points for Sonic Healthcare Limited: P/E 16.3, EPS AUD 1.23, beta 0.59 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Sonic Healthcare Limited. Sonic Healthcare Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Sonic Healthcare Limited. Trailing twelve-month EPS for Sonic Healthcare Limited stands at AUD 1.23. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This quarterSep 2025 | Next quarterDec 2025 | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|---|---|
| Average estimate | AUD 0.00 | AUD 0.53 | AUD 1.23 | AUD 1.31 |
| Lowest estimate | AUD 0.00 | AUD 0.53 | AUD 1.17 | AUD 1.22 |
| Highest estimate | AUD 0.00 | AUD 0.53 | AUD 1.39 | AUD 1.44 |
| Number of analysts | 0 | 1 | 13 | 14 |
| A year ago | AUD 1.711 | AUD 1.321 | AUD 1.23 | — |
| Growth vs a year ago | — | — | −0.2% | — |
1The year-ago figure includes one-time items, so growth is not shown.
Revenue estimates
| Total | This quarterSep 2025 | Next quarterDec 2025 | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|---|---|
| Average estimate | AUD 5.01B | AUD 5.28B | AUD 11.08B | AUD 11.56B |
| Lowest estimate | AUD 5.01B | AUD 5.28B | AUD 10.88B | AUD 11.32B |
| Highest estimate | AUD 5.01B | AUD 5.28B | AUD 11.41B | AUD 11.99B |
| Number of analysts | 10 | 1 | 16 | 16 |
| A year ago | AUD 4.79B | AUD 4.53B | AUD 10.95B | — |
| Growth vs a year ago | +4.5% | +16.5% | +1.2% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Sonic Healthcare Limited. Sonic Healthcare Limited has reported as a listed company since 1999. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| ACL.AXAustralian Clinical Labs Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| HLS.AXHealius Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| IDX.AXIntegral Diagnostics Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| SPDESpeedus Corp. | Healthcare | OTC | $416 | ||
| SZLSFStageZero Life Sciences Ltd. | Healthcare | OTC | $61,766 | ||
| TDSGFTelo Genomics Corp. | Healthcare | OTC | $3.8M | ||
| TELO.VTelo Genomics Corp. | Healthcare | TSXV | $4.0M | ||
| THOXFBioPorto A/S | Healthcare | OTC | $73.8M | ||
| TMOThermo Fisher Scientific Inc. | Healthcare | NYSE | $256.7B | ||
| TMO.NEThermo Fisher Scientific Inc. | Healthcare | NEO | — | ||
| TOMDFTodos Medical Ltd. | Healthcare | OTC | $14,081 | ||
| TTOOT2 Biosystems, Inc. | Healthcare | OTC | $11,218 | ||
| TWSTTwist Bioscience Corporation | Healthcare | NASDAQ | $7.7B | ||
| VCYTVeracyte, Inc. | Healthcare | NASDAQ | $2.1B | ||
| VIMGFVimian Group AB (publ) | Healthcare | OTC | $1.5B | ||
| Ticker | Fund | Fund assets | % of the fund |
|---|---|---|---|
| VXUSVanguard Total International Stock ETF | $163.2B in assets | 0.01% | |
| VEAVanguard FTSE Developed Markets ETF | $231.6B in assets | 0.02% | |
| IEFAiShares Core MSCI EAFE ETF | $188.8B in assets | 0.03% | |
| DFIVDimensional - International Value ETF | $22.0B in assets | 0.15% | |
| ADIVSmartETFs Asia Pacific Dividend Builder ETF | $54M in assets | 2.38% | |
| DVYAiShares AsiaPacific Dividend ETF | $68M in assets | 2.20% | |
| RODMHartford Multifactor Developed Markets (ex-US) ETF | $1.6B in assets | 0.46% | |
| GCOWPacer Global Cash Cows Dividend ETF | $3.7B in assets | 0.21% | |
Largest holders first, then the funds most concentrated in SHL.AX.
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Sonic Healthcare Limited, and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Sonic Healthcare Limited. Coverage tracks Sonic Healthcare Limited within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Sonic Healthcare Limited.